Gunnar Engström Selected Research

Blood Proteins (Serum Proteins)

3/2021	The associations between red cell distribution width and plasma proteins in a general population.
1/2021	Methodological considerations for identifying multiple plasma proteins associated with all-cause mortality in a population-based prospective cohort.
1/2021	Plasma Protein Profile of Carotid Artery Atherosclerosis and Atherosclerotic Outcomes: Meta-Analyses and Mendelian Randomization Analyses.
10/2020	Identification of Inflammatory and Disease-Associated Plasma Proteins that Associate with Intake of Added Sugar and Sugar-Sweetened Beverages and Their Role in Type 2 Diabetes Risk.
1/2019	Biomarkers of blood cadmium and incidence of cardiovascular events in non-smokers: results from a population-based proteomics study.
2/2009	Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study.
1/2007	Long-term change in cholesterol in relation to inflammation-sensitive plasma proteins: a longitudinal study.
9/2005	Incidence of myocardial infarction and death in relation to walking-induced calf pain and plasma levels of inflammation-sensitive proteins.
2/2005	Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.
12/2004	Risk of treatment of peripheral arterial disease is related to inflammation-sensitive plasma proteins: a prospective cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gunnar Engström Research Topics

Disease

56	Neoplasms (Cancer) 12/2022 - 01/2002
43	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2002
30	Inflammation (Inflammations) 12/2022 - 12/2002
27	Stroke (Strokes) 11/2022 - 02/2003
23	Hypertension (High Blood Pressure) 12/2021 - 12/2002
20	Ischemic Stroke 01/2022 - 01/2008
19	Atherosclerosis 01/2022 - 03/2005
17	Myocardial Infarction 01/2022 - 01/2002
15	Atrial Fibrillation 01/2022 - 11/2010
12	Heart Failure 11/2022 - 02/2009
10	Obesity 01/2022 - 08/2004
10	Diabetes Mellitus 12/2021 - 10/2012
9	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2012
8	Insulin Resistance 11/2021 - 12/2006
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2014
5	Chronic Renal Insufficiency 10/2021 - 10/2011
5	Peripheral Arterial Disease 07/2021 - 12/2004
5	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2012
5	Abdominal Aortic Aneurysm 01/2021 - 02/2004
5	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2015
4	Venous Thromboembolism 08/2022 - 01/2014
4	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2014
4	Genetic Risk Score 01/2021 - 01/2016
4	Overweight 01/2021 - 08/2004
4	Embolic Stroke 11/2019 - 01/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2022 - 01/2019
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 11/2015
3	Rupture 12/2017 - 01/2014
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 11/2011
3	Coronary Disease (Coronary Heart Disease) 01/2016 - 07/2004
2	Carotid Artery Diseases 01/2022 - 12/2017
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2022 - 01/2021
2	Hyperglycemia 11/2021 - 05/2015
2	Hemorrhagic Stroke 01/2021 - 04/2006
2	Thrombosis (Thrombus) 01/2021 - 01/2013
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2020 - 01/2018
2	Dyslipidemias (Dyslipidemia) 05/2016 - 05/2015
2	Heart Diseases (Heart Disease) 04/2015 - 05/2006

Drug/Important Bio-Agent (IBA)

30	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2008
17	Blood Proteins (Serum Proteins)IBA 03/2021 - 12/2002
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
15	C-Reactive ProteinIBA 01/2021 - 05/2006
14	CadmiumIBA 01/2021 - 01/2014
11	Orosomucoid (Seromucoid)IBA 01/2017 - 12/2002
10	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2021 - 07/2009
10	HaptoglobinsIBA 01/2017 - 12/2002
10	Ceruloplasmin (Ferroxidase)IBA 01/2017 - 12/2002
10	Fibrinogen (Factor I)FDA Link 10/2012 - 12/2002
8	Cystatin CIBA 01/2021 - 07/2009
8	HDL CholesterolIBA 01/2021 - 11/2009
7	CholesterolIBA 01/2021 - 01/2007
7	LDL CholesterolIBA 01/2021 - 11/2009
7	Natriuretic PeptidesIBA 11/2019 - 07/2009
7	LipidsIBA 01/2018 - 12/2003
6	CalciumIBA 01/2022 - 11/2020
6	oxidized low density lipoproteinIBA 01/2022 - 11/2009
6	Triglycerides (Triacylglycerol)IBA 12/2021 - 01/2007
6	Atrial Natriuretic Factor (ANF)IBA 01/2021 - 11/2010
5	Urokinase Plasminogen Activator ReceptorsIBA 03/2017 - 01/2014
4	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 11/2010
4	Growth Differentiation Factor 15IBA 10/2021 - 01/2019
4	proadrenomedullinIBA 01/2021 - 07/2009
4	GoldIBA 03/2018 - 03/2012
4	Glucose (Dextrose)FDA LinkGeneric 05/2015 - 10/2004
3	Advanced Glycation End ProductsIBA 01/2022 - 01/2019
3	EnzymesIBA 01/2022 - 07/2012
3	Peptides (Polypeptides)IBA 01/2022 - 08/2015
3	AnticoagulantsIBA 01/2022 - 11/2019
3	CreatinineIBA 12/2021 - 03/2017
3	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2017
3	proneurotensinIBA 01/2021 - 10/2012
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2021 - 01/2017
3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 08/2008
3	Complement C3 (C3 Complement)IBA 01/2019 - 06/2007
3	Caspase 8 (Caspase-8)IBA 01/2018 - 01/2017
3	Hormones (Hormone)IBA 11/2017 - 04/2006
3	Growth Hormone (Somatotropin)IBA 10/2017 - 10/2014
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2017 - 04/2014
3	SaltsIBA 02/2014 - 03/2011
2	Pharmaceutical PreparationsIBA 11/2022 - 05/2015
2	Immunoglobulin M (IgM)IBA 01/2022 - 01/2018
2	factor V LeidenIBA 01/2022 - 01/2018
2	ProteomeIBA 01/2022 - 12/2019
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 08/2021
2	Air Pollutants (Pollutants, Air)IBA 01/2022 - 12/2020
2	Vasopressins (Vasopressin)IBA 12/2021 - 04/2015
2	Genetic Markers (Genetic Marker)IBA 01/2021 - 12/2017
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021 - 01/2019
2	AdrenomedullinIBA 01/2021 - 11/2010
2	MetalsIBA 01/2019 - 01/2019
2	SmokeIBA 01/2018 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017 - 01/2016
2	P-2 (P 2)IBA 04/2017 - 10/2014
2	Troponin IIBA 01/2017 - 07/2011
2	Codon (Codons)IBA 03/2016 - 01/2015
2	Insulin (Novolin)FDA Link 08/2015 - 08/2014

Therapy/Procedure

7	Therapeutics 11/2022 - 04/2006
3	Hormone Replacement Therapy (Therapy, Hormone Replacement) 08/2014 - 01/2002
2	Carotid Endarterectomy 01/2019 - 10/2015
2	Secondary Prevention 04/2016 - 07/2011